These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 3002967

  • 1. Effects of anti-Tac antibody on the response of large granular lymphocytes to interleukin-2.
    Mukaida N, Kasahara T, Hosoi J, Shioiri-Nakano K, Kawai T.
    Immunology; 1986 Jan; 57(1):137-43. PubMed ID: 3002967
    [Abstract] [Full Text] [Related]

  • 2. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
    Harel-Bellan A, Bertoglio J, Quillet A, Marchiol C, Wakasugi H, Mishall Z, Fradelizi D.
    J Immunol; 1986 Apr 01; 136(7):2463-9. PubMed ID: 3005412
    [Abstract] [Full Text] [Related]

  • 3. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR, Mason AT, Gerard JP, Henderson LE, Farrar W, Hopkins RF, Herberman RB, Rabin H.
    J Immunol; 1984 Aug 01; 133(2):779-83. PubMed ID: 6203980
    [Abstract] [Full Text] [Related]

  • 4. Production of lymphokines by circulating human T lymphocytes that express or lack receptors for interleukin 2.
    Palacios R.
    J Immunol; 1984 Apr 01; 132(4):1833-6. PubMed ID: 6321592
    [Abstract] [Full Text] [Related]

  • 5. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ, Ronteltap CP, Gravekamp C, Monnikendam D, Bolhuis RL.
    J Immunol; 1986 Mar 01; 136(5):1700-7. PubMed ID: 3005399
    [Abstract] [Full Text] [Related]

  • 6. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL, Herberman RB, Olszowy MW, Cramer DV, Salup RR, Reynolds CW, Hiserodt JC.
    Cancer Res; 1988 Feb 15; 48(4):884-90. PubMed ID: 3257412
    [Abstract] [Full Text] [Related]

  • 7. Regulation of human natural killer cell activity by interferon-gamma: lack of a role in interleukin 2-mediated augmentation.
    Sayers TJ, Mason AT, Ortaldo JR.
    J Immunol; 1986 Mar 15; 136(6):2176-80. PubMed ID: 3081640
    [Abstract] [Full Text] [Related]

  • 8. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
    Schmidt RE, Hercend T, Fox DA, Bensussan A, Bartley G, Daley JF, Schlossman SF, Reinherz EL, Ritz J.
    J Immunol; 1985 Jul 15; 135(1):672-8. PubMed ID: 3923116
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of recombinant interleukin-2 on resting human T lymphocytes.
    Hammer SM, Gillis JM.
    J Biol Response Mod; 1986 Feb 15; 5(1):36-44. PubMed ID: 3007679
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regulation of IFN-gamma induction in human peripheral blood cells by exogenous and endogenously produced interleukin 2.
    Vilcek J, Henriksen-Destefano D, Siegel D, Klion A, Robb RJ, Le J.
    J Immunol; 1985 Sep 15; 135(3):1851-6. PubMed ID: 3926889
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH, Hooks JJ, Quinnan GV, Lane HC, Manischewitz JF, Macher AM, Masur H, Fauci AS, Djeu JY.
    J Immunol; 1985 Mar 15; 134(3):1503-7. PubMed ID: 3918102
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.